ID   NCC-ASPS2-C1
AC   CVCL_E2T7
RX   PubMed=38478355;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 26 hours (PubMed=38478355).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13825; ASPSCR1 + HGNC; HGNC:11752; TFE3; Name(s)=ASPSCR1-TFE3, ASPL-TFE3; Note=ASPCR1 exon 7 fused to TFE3 exon 5 (PubMed=38478355).
CC   Derived from site: In situ; Abdominal wall, hypodermis; UBERON=UBERON_0003697+UBERON_0002072.
ST   Source(s): PubMed=38478355
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D21S11: 29,30
ST   D5S818: 9,11
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3750; Alveolar soft part sarcoma
DI   ORDO; Orphanet_163699; Alveolar soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
RX   PubMed=38478355; DOI=10.1007/s13577-024-01039-0;
RA   Osaki J., Noguchi R., Yanagihara K., Ono T., Adachi Y., Iwata S.,
RA   Toda Y., Sekita T., Kobayashi E., Kojima N., Yoshida A., Kawai A.,
RA   Kondo T.;
RT   "Establishment and characterization of NCC-ASPS2-C1: a novel
RT   patient-derived cell line of alveolar soft part sarcoma.";
RL   Hum. Cell 37:865-873(2024).
//